Search

everythinglearnresearchcommunity

for

Search:↓

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Chemotherapy harms healthy cells, causing side effects like hair loss and reduced immunity.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Drug repurposing finds new uses for existing drugs, saving time and money.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

The treatment combination is effective and generally safe for lung cancer.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Breast cancer patients undergoing chemotherapy often worry, lose weight, and cope by praying, meditating, or seeking support.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Scalp cooling and minoxidil can help manage hair loss in children with cancer, but more research is needed.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.